SCHEMBL20172751

SCHEMBL20172751

Cc1cc(-c2cc(C)c(-n3c4ccccc4c4ccccc43)cc2C)c(C)cc1-c1cc(-c2ccccc2)cc(-c2ccccc2)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.37
ATM Q13315 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
ALDH1A1 P00352 1/20 0.36
HSD17B10 Q99714 1/20 0.35
ESR2 Q92731 1/20 0.33
DHFR P00374 1/20 0.32
HPGD P15428 1/20 0.32
ALKBH5 Q6P6C2 1/20 0.32
FTO Q9C0B1 1/20 0.32
GPR3 P46089 1/20 0.32
TSHR P16473 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
NQO2 P16083 1/20 0.31
POLB P06746 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
PIK3R2 O00459 1/20 0.31
EGFR P00533 1/20 0.30
BRD4 O60885 1/20 0.30
TSPO P30536 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10100817 0.87 KDM4E (0.42) KDM4EATML3MBTL1ALDH1A1HSD17B10
SCHEMBL12938562 0.86 KDM4E (0.38) KDM4EATML3MBTL1ALDH1A1HSD17B10
SCHEMBL13620161 0.84 TSPO (0.34) KDM4EATML3MBTL1ALDH1A1HSD17B10
SCHEMBL25643206 0.83 HSD17B10 (0.42) KDM4EATML3MBTL1ALDH1A1HSD17B10
SCHEMBL13620139 0.82 TSPO (0.34) KDM4EATML3MBTL1ALDH1A1HSD17B10
SCHEMBL7605444 0.82 KDM4E (0.37) KDM4EATML3MBTL1ALDH1A1HSD17B10
SCHEMBL19269985 0.82 L3MBTL1 (0.40) KDM4EATML3MBTL1ALDH1A1HSD17B10
SCHEMBL19269416 0.82 L3MBTL1 (0.40) KDM4EATML3MBTL1ALDH1A1HSD17B10
SCHEMBL17589457 0.81 HSD17B10 (0.41) KDM4EATML3MBTL1ALDH1A1HSD17B10
SCHEMBL13669430 0.81 KDM4E (0.33) KDM4EATML3MBTL1ALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10629817-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2020-04-21 US disclosed
US-20180145260-A1 MATERIALS FOR ORGANIC ELECTRLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2018-05-24 US disclosed
US-20180145260-A1 MATERIALS FOR ORGANIC ELECTRLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2018-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180145260-A1 MATERIALS FOR ORGANIC ELECTRLUMINESCENT DEVICES KCNB2, KCNB1, GJB2 KDM4E 3737/4885ATM 2814/4885L3MBTL1 2807/4885
US-10629817-B2 Materials for organic electroluminescent devices KCNB2, KCNB1, GJB2 KDM4E 3816/4885ATM 3054/4885L3MBTL1 2626/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.